Wayfinding Financial, LLC Amgen Inc Transaction History

Wayfinding Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$262.75 - $319.31 $2,364 - $2,873	-9 Reduced 1.21%	732 $228,000
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $537 - $649	2 Added 0.27%	741 $210,000
Q4 2023 Jan 09, 2024	BUY	$255.7 - $288.46 $188,962 - $213,171	739 New	739 $213,000
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $212,310 - $269,766	927 New	927 $207,000
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $692 - $770	3 Added 0.3%	1,010 $245,000
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $17,541 - $19,405	80 Added 8.63%	1,007 $238,000
Q4 2021 Jan 28, 2022	BUY	$198.88 - $227.6 $184,361 - $210,985	927 New	927 $207,000

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Wayfinding Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Wayfinding Financial, LLC with notifications on news.